"Compared with those prescribed lifestyle intervention for obesity, adolescents prescribed either liraglutide (Saxenda; Novo Nordisk) or semaglutide (Wegovy; No

"Compared with those prescribed lifestyle intervention for obesity, adolescents prescribed either liraglutide (Saxenda; Novo Nordisk) or semaglutide (Wegovy; Novo Nordisk) had a 33% lower risk of suicidality over 12 months of follow-up after controlling for potential baseline confounders."[1] [1]https://www.tctmd.com/news/defying-earlier-glp-1-data-study-teens-sees-possible-mental-health-gains https://www.tctmd.com/news/defying-earlier-glp-1-data-study-...